BPC-157: What the Evidence Actually Supports
A citation-first read on the most hyped repair peptide, mechanism, the rodent data, the missing human trials and the risk nobody markets.
Archive
Every peptide we've read the literature on, written up with mechanisms, dosing ranges and an honest read on study quality.
A citation-first read on the most hyped repair peptide, mechanism, the rodent data, the missing human trials and the risk nobody markets.
Semaglutide, tirzepatide and what comes next, incretin biology, the actual trial numbers, and the questions the headlines skip.
Purity percentage, net peptide content, HPLC traces and mass spec, a plain-language guide to verifying what is actually in the vial.
Where the dermatology evidence is genuinely strong, where the systemic claims collapse, and why formulation decides the outcome.
Combination protocols are extrapolations layered on extrapolations. Here is the reasoning framework, and why most stacks fail it at step one.